| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8b3186ebe6d5d35e4aff2ab3437c5fc |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-32 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 |
| filingDate |
2012-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e0b7233536cd5846954d03834ea4201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49365b5d3c883afe493564bd35c81baf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16d4eb5de2d3bf3ba280861bc0d035d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7652766b94178177794d17bfba34471
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35af020c3d46fbcd3a3fe1917c864272
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90cb69219ea179c079efeaa2ce7eafea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3111398e5d5fbba8a4ac6d8b65a01ec1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_710ed8fef8d92569940c24a1f4edec27 |
| publicationDate |
2021-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-102012024276-B1 |
| titleOfInvention |
method and preclinical test to obtain a vaccine using bacillus calmette-guérin (bcg) and mycobacterium smegmatis that express the virulence factors bfpa and intimin of enteropathogenic Escherichia coli (epec) |
| abstract |
method and pre-clinical test to obtain a vaccine using bacillus calmette-guérin (bcg) and mycobacterium smegmatis that express the virulence factors bfpa and intimin of enteropathogenic escrerichia coli (epec). The present invention relates to the method for obtaining a vaccine using bacillus calmette-guerin (bcg) (vaccine against tuberculosis) and mycobacterium smegmatis (acid-alcohol resistant bacteria species of the mycobacterium genus) expressing the virulence factors of the bfpa gene and intimin of enteropathogenic escherichia coli (epec). the vaccine strain of the present invention is used to activate the immune system to produce local protection against challenges with virulent strains of epec. |
| priorityDate |
2012-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |